SEARCH
Enter your search term below:
Close
Enter your search term below:
WORLD LEADING BUSINESS SUPPORT
Azellon Ltd, (“Azellon”), a spin-out from the University of Bristol and the developer of stem cell therapies for tissue repair, today announced that recruitment had commenced for the phase I/IIa trial of its Cell Bandage for knee meniscus repair.
Built upon the pioneering work of Professor Anthony Hollander from the University’s School of Cellular and Molecular Medicine, the Azellon procedure takes stem cells, harvested from the patient’s own bone marrow, grows them on a structural bio-scaffold, and two weeks later implants the newly created Cell Bandage into the patient’s knee.
Read the full story on the University website
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close
RT @setsquared: Registration is open for our Sustainable Technologies Business Acceleration Hub | February 2020 @SETsquared_Br | A… https://t.co/c6hEOjBdMK
SETsquared news: Exciting event news & a new funding call has opened! - mailchi.mp/setsquared/setsquar… pic.twitter.com/2emp3EgWSi
SETsquared news: Exciting event news & a new funding call has opened! - mailchi.mp/setsquared/setsquar… pic.twitter.com/bu88G4iWZH
Are you looking for academic partners to help develop your #agritech product or service? Our One Health campaign co… twitter.com/i/web/status/12054…
"Success is not just about money, it's about finding people who share your vision." - an interesting overview of th… twitter.com/i/web/status/12053…
SETsquared is a partnership between